Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Toxicology|January 18, 2014
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challengesSlawo Lomnicki, Brian Gullett, Tobias Stöger, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PETMichael D Devous, Adam S Fleisher, Michael J Pontecorvo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2018
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scaleMichael Navitsky, Abhinay D Joshi, Ian Kennedy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathologySamantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2025
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
Brain : a Journal of Neurology|April 23, 2019
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementiaMichael J Pontecorvo, Michael D Devous, Ian Kennedy, et al.
BMJ Open|October 30, 2021
Protocol for the development of a core outcome set for studies of pregnant women with pre-existing multimorbiditySiang Ing Lee, Kelly-Ann Eastwood, Ngawai Moss, et al.
Pageof 4